The chemical class of SARA Activators consists of compounds that indirectly influence the activity of SARA (ZFYVE9) by modulating the TGF-β signaling pathway, to which SARA is closely linked. These activators function by impacting the interaction between SARA and other components of the TGF-β signaling cascade. Compounds like SB431542, LY364947, and GW788388 are inhibitors of TGF-β type I receptors and can alter the dynamics of TGF-β signaling, indirectly influencing SARA's role in this pathway. By modulating the activity of TGF-β receptors, these compounds can affect the recruitment and activation of SMAD proteins by SARA, which is a critical step in propagating TGF-β signals.
Other activators in this class, such as Reparixin, Pirfenidone, and Tranilast, have different mechanisms but can also impact TGF-β signaling. For example, Pirfenidone, with its anti-fibrotic properties, may alter TGF-β signaling, thereby influencing SARA's interaction with SMAD proteins in fibrotic processes. Similarly, compounds like Halofuginone and Dorsomorphin, by modulating related signaling pathways, can indirectly affect SARA's function within the TGF-β/SMAD signaling network.
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
A 83-01 | 909910-43-6 | sc-203791 sc-203791A | 10 mg 50 mg | $202.00 $811.00 | 16 | |
Inhibits TGF-β type I receptors, potentially affecting SARA-mediated SMAD recruitment. | ||||||
Reparixin | 266359-83-5 | sc-507446 | 5 mg | $78.00 | ||
An inhibitor of CXCR1/2, can influence inflammatory pathways, indirectly affecting SARA in TGF-β signaling. | ||||||
Pirfenidone | 53179-13-8 | sc-203663 sc-203663A | 10 mg 50 mg | $102.00 $416.00 | 6 | |
An anti-fibrotic drug that can modulate TGF-β signaling, potentially affecting SARA's interaction with SMAD proteins. | ||||||
Tranilast | 53902-12-8 | sc-200389 sc-200389A sc-200389B sc-200389C | 10 mg 50 mg 1 g 5 g | $31.00 $103.00 $283.00 $978.00 | 2 | |
Modulates release of TGF-β, potentially affecting SARA's role in TGF-β signaling pathways. | ||||||
Halofuginone | 55837-20-2 | sc-507290 | 100 mg | $1775.00 | ||
An inhibitor of TGF-β/SMAD3 signaling, might indirectly modulate SARA's activity. | ||||||
BML-275 | 866405-64-3 | sc-200689 sc-200689A | 5 mg 25 mg | $96.00 $355.00 | 69 | |
An inhibitor of BMP signaling, potentially influencing SARA's role in related signaling pathways. | ||||||